These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20090417)

  • 1. Invasive breast cancer development: "fatal accident" from malfunctions in both "motor" and "brake".
    Lu J; Yu D
    Cell Cycle; 2010 Feb; 9(3):421-2. PubMed ID: 20090417
    [No Abstract]   [Full Text] [Related]  

  • 2. 14-3-3zeta Cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transition.
    Lu J; Guo H; Treekitkarnmongkol W; Li P; Zhang J; Shi B; Ling C; Zhou X; Chen T; Chiao PJ; Feng X; Seewaldt VL; Muller WJ; Sahin A; Hung MC; Yu D
    Cancer Cell; 2009 Sep; 16(3):195-207. PubMed ID: 19732720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive ductal carcinoma arising in a breast hamartoma: two case reports and a review of the literature.
    Lee EH; Wylie EJ; Bourke AG; Bastiaan De Boer W
    Clin Radiol; 2003 Jan; 58(1):80-3. PubMed ID: 12565210
    [No Abstract]   [Full Text] [Related]  

  • 4. [Microsatellite instability and allele-specific chromosome 3p deletion in breast cancer and precancerous lesions].
    Fu Q; Yao GY; Tang XL; Chen LR; Zheng ZX
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):34-40. PubMed ID: 17575691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Differential atypical ductal hyperplasia/DCIS/invasive carcinoma diagnosis and significance of micrometastases].
    Stosiek P
    Zentralbl Chir; 1998; 123 Suppl 5():13. PubMed ID: 10063563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathohistological diagnosis of precancerous conditions and cancer of the breast].
    Avtandilov GG; Perov IuL; Grigor'eva SG; Zaĭrat'iants OV
    Arkh Patol; 2001; 63(2):26-30. PubMed ID: 11392088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of 14-3-3 sigma and related proteins in hyperplastic and neoplastic breast lesions, with particular reference to early carcinogenesis.
    Simooka H; Oyama T; Sano T; Horiguchi J; Nakajima T
    Pathol Int; 2004 Aug; 54(8):595-602. PubMed ID: 15260850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microglandular adenosis with transition to breast carcinoma: a series of three cases.
    Lin L; Pathmanathan N
    Pathology; 2011 Aug; 43(5):498-503. PubMed ID: 21753716
    [No Abstract]   [Full Text] [Related]  

  • 9. Stages on the way to breast cancer.
    Going JJ
    J Pathol; 2003 Jan; 199(1):1-3. PubMed ID: 12474219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis and VEGF expression in pre-invasive lesions of the human breast.
    Viacava P; Naccarato AG; Bocci G; Fanelli G; Aretini P; Lonobile A; Evangelista G; Montruccoli G; Bevilacqua G
    J Pathol; 2004 Oct; 204(2):140-6. PubMed ID: 15376259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of survivin in different stages of carcinogenesis and progression of breast cancer].
    Zhang SQ; Qiang SY; Yang WB; Jiang JT; Ji ZZ
    Ai Zheng; 2004 Jun; 23(6):697-700. PubMed ID: 15191674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lobular lesions of the breast: imaging findings of lobular neoplasia and invasive lobular carcinoma.
    Choi BB; Kim SH; Shu KS
    J Reprod Med; 2012; 57(1-2):26-34. PubMed ID: 22324264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast-duct endoscopy to study stages of cancerous breast disease.
    Love SM; Barsky SH
    Lancet; 1996 Oct; 348(9033):997-9. PubMed ID: 8855857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of Fhit protein is related inversely to disease progression in patients with breast carcinoma.
    Gatalica Z; Lele SM; Rampy BA; Norris BA
    Cancer; 2000 Mar; 88(6):1378-83. PubMed ID: 10717620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphology of the premalignant lesions of the breast.
    Saksela E
    Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():11-6. PubMed ID: 8298439
    [No Abstract]   [Full Text] [Related]  

  • 16. Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions.
    Weinstat-Saslow D; Merino MJ; Manrow RE; Lawrence JA; Bluth RF; Wittenbel KD; Simpson JF; Page DL; Steeg PS
    Nat Med; 1995 Dec; 1(12):1257-60. PubMed ID: 7489405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HER2 as a prognostic factor in breast cancer.
    Ménard S; Fortis S; Castiglioni F; Agresti R; Balsari A
    Oncology; 2001; 61 Suppl 2():67-72. PubMed ID: 11694790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship of ezrin protein expression to the carcinogenesis and prognosis of infitrating breast ductal carcinoma].
    Ma L; Zhang XH; Xing LX; Li YH; Wang XL; Wang YJ
    Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):279-83. PubMed ID: 18788632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraductal spread of invasive breast carcinoma has a positive correlation with c-erb B-2 overexpression and vascular invasion.
    Jing X; Kakudo K; Murakami M; Nakamura Y; Nakamura M; Yokoi T; Yang Q; Oura S; Sakurai T
    Cancer; 1999 Aug; 86(3):439-48. PubMed ID: 10430252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of growth pattern and extension of tumor-associated intraductal carcinoma of the breast.
    Eggemann H; Kalinski T; Ruhland AK; Ignatov T; Costa SD; Ignatov A
    Clin Breast Cancer; 2015 Jun; 15(3):227-33. PubMed ID: 25516401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.